Cholangiocarcinoma

Overview

Cholangiocarcinoma is also a rare cancer with approximately 5,000 cases diagnosed each year in the US. Patients are usually in theirs sixties. Risk factors include primary sclerosing cholangitis, hepatolithiasis, choledochal cysts, or liver fluke infection. Symptoms include weigh loss, jaundice, right upper quadrant pain, fever, and palpable mass. Diagnosis and imaging include liver MRI, MRCP, or abdominal CT. An ERCP is often needed for diagnosis.

Treatment Options

Treatment options include surgery, adjuvant chemotherapy, chemoradiation, radiofrequency ablation or chemotherapy alone. Chemotherapy agents include 5-FU, oxaliplatin, cisplatin, and gemzar.

Cholangiocarcinoma Specialists

Raymond Tsao, MD

Dr. Raymond Tsao

Dr. Tsao is board certified in medical oncology and hematology. He is currently seeing patients with all types of cancer, with a focus on hematologic and gastrointestinal malignancies, including esophageal, stomach, colorectal and pancreatic cancer. Dr. Tsao is a member of the American Society of Clinical Oncology and American Society of Hematology.

Click here to learn more about Dr. Raymond Tsao.

Dr. Vijay Narendran

Dr. Vijay Narendran

Dr. Narendran is board certified in medical oncology and hematology. Dr. Narendran treats a variety of cancers and has a special interest in gastrointestinal and hematologic malignancies. Dr. Narendran is a member of the American Society of Clinical Oncology and the American Society of Hematology.

Click here to learn more about Dr. Vijay Narendran.

Share This